.png)
.png)
Orthoclone OKT3® was the first monoclonal antibody-based drug (approved in 1986).
...read more.png)
Owing to its highly cost and time intensive nature, the development of a novel molecu
...read more.png)
From periodically monitoring disease progression in patients to developing customized
...read more.png)
With close to 80 monoclonal antibodies approved till date, and over 550 molecules in
...read more.png)
Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders,
...read more.png)
Recent advances in the manufacturing technologies have prompted pharmaceutical compan
...read moreAdvances in 3D cell culturing, have led to the discovery of better scaffold fabrication techniques and a
...read moreHuman factors engineering and usability testing have now become an essential part of product design acro
...read moreSTING pathway modulation, using appropriate pharmacological interventions, has emerged as a viable appro
...read more
Reports
Major Pharma Markets
Clients
Analytical Frameworks
We are your partners with no equity
We fit in your budget
We love what we do
chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
